Garcia-Merino A - Search Results

1

Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis.

Moreno Torres I, Sanchez AJ, Garcia-Merino A. Moreno Torres I, et al. Expert Rev Neurother. 2014 Nov;14(11):1243-50. doi: 10.1586/14737175.2014.971758. Expert Rev Neurother. 2014. PMID: 25331416 Review.

2

Changes in cannabinoid CB(1) receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis.

Berrendero F, Sánchez A, Cabranes A, Puerta C, Ramos JA, García-Merino A, Fernández-Ruiz J. Berrendero F, et al. Synapse. 2001 Sep 1;41(3):195-202. doi: 10.1002/syn.1075. Synapse. 2001. PMID: 11391780

3

[Multiple sclerosis in the XXI century].

García Merino A. García Merino A. Neurologia. 2004 Dec;19(10):728-34. Neurologia. 2004. PMID: 15568170 Review. Spanish.

4

Rolipram impairs NF-kappaB activity and MMP-9 expression in experimental autoimmune encephalomyelitis.

Sánchez AJ, Puerta C, Ballester S, González P, Arriaga A, García-Merino A. Sánchez AJ, et al. J Neuroimmunol. 2005 Nov;168(1-2):13-20. doi: 10.1016/j.jneuroim.2005.03.024. Epub 2005 Sep 22. J Neuroimmunol. 2005. PMID: 16182379

5

Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.

Cabranes A, Venderova K, de Lago E, Fezza F, Sánchez A, Mestre L, Valenti M, García-Merino A, Ramos JA, Di Marzo V, Fernández-Ruiz J. Cabranes A, et al. Neurobiol Dis. 2005 Nov;20(2):207-17. doi: 10.1016/j.nbd.2005.03.002. Neurobiol Dis. 2005. PMID: 16242629

6

R-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo-[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphtalenylmethanone (WIN-2) ameliorates experimental autoimmune encephalomyelitis and induces encephalitogenic T cell apoptosis: partial involvement of the CB(2) receptor.

Sánchez AJ, González-Pérez P, Galve-Roperh I, García-Merino A. Sánchez AJ, et al. Biochem Pharmacol. 2006 Dec 15;72(12):1697-706. doi: 10.1016/j.bcp.2006.08.018. Epub 2006 Aug 26. Biochem Pharmacol. 2006. PMID: 17007821

7

Multiple sclerosis associates with LILRA3 deletion in Spanish patients.

Ordóñez D, Sánchez AJ, Martínez-Rodríguez JE, Cisneros E, Ramil E, Romo N, Moraru M, Munteis E, López-Botet M, Roquer J, García-Merino A, Vilches C. Ordóñez D, et al. Genes Immun. 2009 Sep;10(6):579-85. doi: 10.1038/gene.2009.34. Epub 2009 May 7. Genes Immun. 2009. PMID: 19421224

8

The cannabinoid receptor 1 gene (CNR1) and multiple sclerosis: an association study in two case-control groups from Spain.

Ramil E, Sánchez AJ, González-Pérez P, Rodríguez-Antigüedad A, Gómez-Lozano N, Ortiz P, Arroyo R, De las Heras V, Vilches C, García-Merino A. Ramil E, et al. Mult Scler. 2010 Feb;16(2):139-46. doi: 10.1177/1352458509355071. Epub 2009 Dec 9. Mult Scler. 2010. PMID: 20007426

9

Neuroprotective agents: cannabinoids.

Sánchez AJ, García-Merino A. Sánchez AJ, et al. Clin Immunol. 2012 Jan;142(1):57-67. doi: 10.1016/j.clim.2011.02.010. Epub 2011 Mar 21. Clin Immunol. 2012. PMID: 21420365 Review.

10

IL28B polymorphisms are not associated with the response to interferon-β in multiple sclerosis.

Malhotra S, Morcillo-Suárez C, Brassat D, Goertsches R, Lechner-Scott J, Urcelay E, Fernández O, Drulovic J, García-Merino A, Martinelli Boneschi F, Chan A, Vandenbroeck K, Navarro A, Bustamante MF, Río J, Akkad DA, Giacalone G, Sánchez AJ, Leyva L, Alvarez-Lafuente R, Zettl UK, Oksenberg J, Montalban X, Comabella M. Malhotra S, et al. J Neuroimmunol. 2011 Oct 28;239(1-2):101-4. doi: 10.1016/j.jneuroim.2011.08.004. Epub 2011 Sep 1. J Neuroimmunol. 2011. PMID: 21889215

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

86 results

Search Page